- Q4 2024 Natco Pharma Ltd Earnings Call TranscriptMay 28, 2024₹1032.3 (+0.28%)Earnings
- Q3 2024 Natco Pharma Ltd Earnings Call TranscriptFeb 15, 2024₹887.1 (+0.26%)Earnings
- Q2 2024 Natco Pharma Ltd Earnings Call TranscriptNov 15, 2023₹758.65 (-4.48%)Earnings
- Natco Pharma Ltd Annual Shareholders Meeting TranscriptSep 29, 2023
- Q1 2024 Natco Pharma Ltd Earnings Call TranscriptAug 10, 2023₹876.05 (-1.97%)Earnings
- Q4 2023 Natco Pharma Ltd Earnings Call TranscriptMay 30, 2023₹619.5 (-2.15%)Earnings
- Q3 2023 Natco Pharma Ltd Earnings Call TranscriptFeb 10, 2023₹524.85 (-0.88%)Earnings
- Q2 2023 Natco Pharma Ltd Earnings Call TranscriptNov 11, 2022₹584 (-0.72%)Earnings
- Q1 2023 Natco Pharma Ltd Earnings Call TranscriptAug 10, 2022₹672.85 (-10.35%)Earnings
- Q4 2022 Natco Pharma Ltd Earnings Call TranscriptMay 31, 2022₹690.95 (+3.72%)Earnings
- Q3 2022 Natco Pharma Ltd Earnings Call TranscriptFeb 15, 2022₹895.35 (-2.40%)Earnings
- Q2 2022 Natco Pharma Ltd Earnings Call TranscriptNov 12, 2021₹828.7 (+0.55%)Earnings
- Q1 2022 Natco Pharma Ltd Earnings Call TranscriptAug 12, 2021₹1041.45 (+3.06%)Earnings
- Q4 2021 Natco Pharma Ltd Earnings Call TranscriptJun 18, 2021₹1095.8 (+1.25%)Earnings
- Q3 2021 Natco Pharma Ltd Earnings Call TranscriptFeb 12, 2021₹854 (-3.64%)Earnings
- Q2 2021 Natco Pharma Ltd Earnings Call TranscriptNov 13, 2020₹900.9 (-0.63%)Earnings
- Q1 2021 Natco Pharma Ltd Earnings Call TranscriptAug 13, 2020₹813.4 (-4.17%)Earnings
- Q4 2020 Natco Pharma Ltd Earnings Call TranscriptJun 18, 2020₹620.05 (+0.99%)Earnings
- Q3 2020 Natco Pharma Ltd Earnings Call TranscriptFeb 13, 2020₹673.95 (-4.91%)Earnings
- Q2 2020 Natco Pharma Ltd Earnings Call TranscriptNov 13, 2019₹560.15 (-3.19%)Earnings
- Q1 2020 Natco Pharma Ltd Earnings Call TranscriptAug 09, 2019₹551.45 (-0.27%)Earnings
- Q4 2019 Natco Pharma Ltd Earnings Call TranscriptMay 28, 2019₹529.9 (+0.94%)Earnings
Q2 2022 Natco Pharma Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Q2 FY '22 Earnings Conference Call of NATCO Pharma hosted by Investec Capital Services. (Operator Instructions) And there will be an opportunity for you to ask questions after the presentation concludes. (Operator Instructions) I now hand the conference over to Ms. Swapna Bhandarkar for Investec Capital Services. Thank you, and over to you, ma'am.
Thanks, Jacob, and Good morning, everybody. Firstly, let me apologize for the delay. We were facing some technical issue on our side. Having said that, I welcome all to the Q2 FY '22 earnings call of NATCO Pharma. We have with us the management of the company, Mr. Rajeev Nannapaneni. He's the Vice Chairman and Executive -- Chief Executive Officer. Joining him is Mr. Rajesh Chebiyam. He's the EVP and for Crop Health Sciences and Head of Investor Relations. Good morning, gentlemen, and I now hand over this call to Mr. Rajeev to make the opening remarks, post which we will begin the Q&A session. Thank you.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)